Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

278

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

278 results for “sarcoidosis”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov20/100

Biomaterial Collection - and Analysis in Cardiac Sarcoidosis

ClinicalTrials.gov study NCT05793398. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

ClinicalTrials.gov study NCT05890729. IPD Sharing: Not stated. Countries: 6. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

18F-FDG PET Imaging in Cardiac Sarcoidosis

ClinicalTrials.gov study NCT01764191. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

A Phase 2 Study With CC-220 in Skin Sarcoidosis

ClinicalTrials.gov study NCT02192489. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

ClinicalTrials.gov study NCT00690911. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov20/100

Comparison of Characteristics of Bronchoalveolar Lavage Dusting and of Specific Questionnary Data in Healthy Volunteers and Patients Suffering From Sarcoidosis

ClinicalTrials.gov study NCT02863406. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov20/100

Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis

ClinicalTrials.gov study NCT05910554. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
geo20/100

Single-cell and spatial architecture of human tissue granulomas reveals an aberrant immune-regulatory program underlying sarcoidosis

GEO Series GSE192461. Homo sapiens. 57 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2023View details →
geo20/100

Effects of azithromycin on blood inflammatory gene expression and cytokine production in sarcoidosis

GEO Series GSE274707. Homo sapiens. 32 samples. Type: Expression profiling by array.

openGEO-OpenAug 2024View details →
geo16/100

RNA-seq of control and sarcoidosis human nasal airway epithelial cell cultures

GEO Series GSE252763. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2026View details →
geo16/100

Spatial transcriptomic signatures of cardiac sarcoidosis

GEO Series GSE314910. Homo sapiens. 12 samples. Type: Other.

openGEO-OpenJan 2026View details →
geo16/100

Single Cell Transcriptome Signatures of Sarcoidosis in Lung Immune Cell Populations

GEO Series GSE288459. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2026View details →
geo16/100

Activity of the GHRH Antagonist MIA-602 and its Underlying Mechanisms of Action in sarcoidosis

GEO Series GSE156397. Mus musculus. 3 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenAug 2023View details →
geo16/100

Sarcoidosis miRNA Blood Profiles

GEO Series GSE26409. Homo sapiens. 100 samples. Type: Non-coding RNA profiling by array.

openGEO-OpenJan 2013View details →
geo12/100

Trancriptional signatures of dexamethasone-treated sarcoidosis alveolar macrophages (AMs)

GEO Series GSE150842. Homo sapiens. 20 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenMay 2020View details →
geo12/100

Trancriptional signatures of dexamethasone-treated sarcoidosis monocytes.

GEO Series GSE150049. Homo sapiens. 20 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenMay 2020View details →
zenodo12/100

Serum metabolic disparity between pulmonary Sarcoidosis (SAR) and Tuberculosis (TB) revealed by NMR based metabolomics study

<p>Tuberculosis (TB) -a pulmonary granulomatous disease- is the leading cause of death worldwide from a single infectious disease agent especially in developing countries such as India. Current diagnostic methodologies often lack specificity and sensitivity; therefore, there is an immense clinical interest to investigate alternative biomarker signatures for obtaining a conclusive and suggestive diagnosis of TB. Particular challenge arises for treating physicians while differentiating TB from sarcoidosis (SAR) which is an uncommon granulomatous disease and shares the similar clinical, radiological and pathological features with TB. Symptoms common in TB such as cough, fever, fatigue, and weight-loss are often manifested in sarcoidosis as well. As India accounts for more than 26% of global burden of TB cases and epidemiological data about sarcoidosis is unknown, most of the sarcoidosis patients end up receiving anti tubercular therapy (ATT) erroneously, leading to delayed proper treatment and considerable risk of drug induced toxicity, whereas lung damage continues to progress in this backdrop. Therefore, there is an urgent unmet need to identify non-invasive biomarker(s) for differentiating sarcoidosis from TB. Metabolomics analysis of serum holds great potential to provide distinctive patterns of metabolic profiles relevant to underlying disease processes and thus may aid in rapid clinical diagnosis and guiding appropriate treatment.</p> <p>Starting our efforts in this direction, the serum metabolic profiles&nbsp;of sarcoidosis and active TB patients were&nbsp;measured using 800 MHz NMR Spectroscopy and compared using the multivariate and univariate statistical analysis tools. The partial least square discriminatory analysis (PLS-DA) revealed significant serum metabolic disparity between SAR and TB with respect to normal control subjects [1-5].&nbsp;Compared to SAR, the sera of TB patients were characterized by (a) elevated levels of lactate, acetate, 3-hydroxybutyrate (3HB), glutamate and succinate (b) decreased levels of glucose, citrate, pyruvate, glutamine, and various lipid and membrane metabolites (such as very-low/low density lipoproteins (VLDL/LDL), polyunsaturated fatty acids, etc.).</p> <p>The altered circulatory levels of glucose (decreased) and lactate (increased) were found well consistent with previous report [6] demonstrating that infection with Mycobacterium tuberculosis (MTb) induces the Warburg effect in mouse lungs. A very recent study reported increased production of glutamate from mitochondrial glutaminolysis and pleiotropic roles of glutamine metabolism in the metabolic reprogramming of MTb infected M1-like macrophages [7]. A previous study published in Science [8] reported the suppression of oxidative stress by 3HB. Another study published in scientific report demonstrated that of <em>Mycobacterium tuberculosis</em> (MTb) secretory protein ESAT-induces GLUT-1 mediated enhanced glucose uptake by macrophages and increased fatty acid biosynthesis (to drive foamy macrophage differentiation) which in turn results in release of 3HB in the extracellular environment [9]. Based on previously reported metabolic derangements in MTb infected systems and our results derived from NMR-based serum metabolomics, the following remarks have been drawn:</p> <ul> <li><strong>Active TB infection </strong>induces Warburg effect as inferred from the decreased serum levels of glucose and elevated levels of lactate</li> <li><strong>Active TB infection </strong>causes increased biosynthesis of fatty acids as inferred from the decreased serum levels of citrate and increased levels of acetate and 3-Hydroxybutyrate (3-HB)</li> <li><strong>Active TB infection </strong>manipulates oxidative stress (OS) induced pathogen killing host-defense mechanism as inferred from decreased circulatory phenylalanine-to-tyrosine ratio (PTR) and 3HB (known to suppress OS)</li> <li><strong>Active TB infection </strong>induces augmented utilization of glutamine (an immunomodulatory nutrient) as inferred from the decreased serum levels of glutamine and increased serum levels of glutamate and succinate</li> <li><strong>Active TB infection </strong>induces&nbsp;dyslipidemia as inferred from the decreased NMR signals of very-low/low density lipoproteins (VLDL/LDL) and polyunsaturated fatty acids (PUFAs)</li> </ul> <p><strong>References:</strong></p> <ol> <li>Dinesh Kumar, Ritu Raj, Avinash Jain , Anupam Guleria, Umesh Kumar, Mohit K Rai, Harshit Singh, Saurabh Chaturvedi, Alok Nath, Durga P Misra and Vikas Agarwal, &ldquo;Serum based metabolomics analysis revealed highly sensitive and specific panel of metabolic markers for differential diagnosis of Pulmonary Sarcoidosis and Tuberculosis&rdquo; (Conference paper presented during IRACON-2018). F1000Research 2019, 8:304 (DOI: 10.7490/f1000research.1116481.1)</li> <li>Dinesh Kumar, Avinash Jain, Amit Kumar, Anupam Guleria, Ritu Raj, Harshit Singh, Mohit K Rai, Saurabh Chaturvedi, Alok Nath, Durga P Misra, and Vikas Agarwal, &ldquo;Targeted nuclear magnetic resonance-based serum metabolomics analysis revealed significantly higher phenylalanine/tyrosine ratio in pulmonary sarcoidosis patients compared to tuberculosis patients&rdquo;, (Conference Paper selected for Oral Presentation in IRACON 2018: OPC0034) Indian J Rheumatol (2018), vol 13 (Issue 6) Suppl S2:79-92 (DOI: 10.4103/0973-3698.247335)</li> <li>Avinash Jain, Amit Kumar, Harshit Singh, Mohit Kumar Rai, Saurabh Chaturvedi, Anupam Guleria, Alok Nath, Dinesh Kumar, Durga Prasanna Misra, and Vikas Agarwal, &ldquo;Nuclear magnetic resonance (NMR) based Serum Metabolomics in Sarcoidosis and Tuberculosis &ndash; Search for a Biomarker&rdquo;, (Received Best Oral Award) (Conference Paper selected for Oral Presentation in IRACON 2018: OPC0030) Indian J Rheumatol (2018), vol 13 (Issue 6) Suppl S2:79-92&nbsp; (DOI: 10.4103/0973-3698.247335).</li> <li>Dinesh Kumar, Avinash Jain, Amit Kumar, Anupam Guleria, Alok Nath, Durga Prasanna Misra, Vikas Agarwal, &ldquo;Diagnostic panel of biomarkers for the assessment of sarcoidosis and tuberculosis identified using NMR based serum metabolomics approach&rdquo; (Poster Presented during BSRAC-2018) F1000Research (2018), 7:18 (doi: 10.7490/f1000research.1115194.1)</li> <li>Avinash Jain, Amit Kumar, Harshit Singh, Mohit K Rai, Saurabh Chaturvedi, Anupam Guleria, Alok Nath, Dinesh Kumar, Durga P Misra and Vikas Agarwal, &ldquo;Nuclear magnetic resonance (NMR) based serum metabolomics in sarcoidosis and tuberculosis: search for a biomarker&rdquo; (Poster Presentation during British Society for Rheumatology Annual Conference 2018 | BSRAC-2018) Rheumatology (April 2018), Vol 57, Issue suppl_3 (DOI: 10.1093/rheumatology/key075.338).</li> <li>Shi, L., Salamon, H., Eugenin, E.A., Pine, R., Cooper, A. and Gennaro, M.L., 2015. Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs. Scientific reports, 5(1), pp.1-13.</li> <li>Jiang, Qingkui, and Lanbo Shi. &quot;Coordination of the uptake and metabolism of amino acids in Mycobacterium tuberculosis-infected macrophages.&quot; Frontiers in Immunology 12 (2021).</li> <li>Shimazu, T., Hirschey, M.D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C.A., Lim, H., Saunders, L.R., Stevens, R.D. and Newgard, C.B., 2013. Suppression of oxidative stress by &beta;-hydroxybutyrate, an endogenous histone deacetylase inhibitor.&nbsp;<em>Science</em>,&nbsp;<em>339</em>(6116), pp.211-214.</li> <li>Singh, V., Kaur, C., Chaudhary, V.K., Rao, K.V. and Chatterjee, S., 2015. M. tuberculosis secretory protein ESAT-6 induces metabolic flux perturbations to drive foamy macrophage differentiation.&nbsp;<em>Scientific reports</em>,&nbsp;<em>5</em>(1), pp.1-12.</li> </ol>

restrictedOct 2021View details →
geo12/100

Genetic characterization of bronchoalveolar lavage fluid cells from patients with IPF and sarcoidosis

GEO Series GSE121500. Homo sapiens. 21 samples. Type: Expression profiling by array.

openGEO-OpenMay 2019View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.